Daniel L. Parsons

742 total citations
30 papers, 549 citations indexed

About

Daniel L. Parsons is a scholar working on Molecular Biology, Pharmaceutical Science and Cell Biology. According to data from OpenAlex, Daniel L. Parsons has authored 30 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Pharmaceutical Science and 7 papers in Cell Biology. Recurrent topics in Daniel L. Parsons's work include Protein Interaction Studies and Fluorescence Analysis (10 papers), Hemoglobin structure and function (6 papers) and Protein Structure and Dynamics (4 papers). Daniel L. Parsons is often cited by papers focused on Protein Interaction Studies and Fluorescence Analysis (10 papers), Hemoglobin structure and function (6 papers) and Protein Structure and Dynamics (4 papers). Daniel L. Parsons collaborates with scholars based in United States, Qatar and United Kingdom. Daniel L. Parsons's co-authors include R. Jayachandra Babu, G. V. Betageri, Virginia A. Davis, William R. Ravis, Vijay Rangari, J.J. Vallner, Oladiran Fasina, Chandra Sekhar Kolli, Anand Gupta and Brian J. Sweetman and has published in prestigious journals such as Journal of Chromatography A, Clinical Chemistry and International Journal of Pharmaceutics.

In The Last Decade

Daniel L. Parsons

30 papers receiving 520 citations

Peers

Daniel L. Parsons

SPECT

BIOMA

Keigo Yamada Japan

Bong-Kyu Yoo South Korea

R.J. Prankerd United States

G Bramanti Italy

Dong Woo Yeom South Korea

Umesh V. Banakar United States

Mamdouh Ghorab Egypt

Krishna Hari Bhandari South Korea

Madhuri Newa South Korea

F. Hirayama Japan

Keigo Yamada Japan

Daniel L. Parsons

508 ×1.9

144 ×0.8

147 ×1.3

60 ×0.9

SPECT

78 ×1.4

BIOMA

Citations per year, relative to Daniel L. Parsons Daniel L. Parsons (= 1×) peers Keigo Yamada

Countries citing papers authored by Daniel L. Parsons

Since Specialization

Citations

This map shows the geographic impact of Daniel L. Parsons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel L. Parsons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel L. Parsons more than expected).

Fields of papers citing papers by Daniel L. Parsons

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel L. Parsons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel L. Parsons. The network helps show where Daniel L. Parsons may publish in the future.

Co-authorship network of co-authors of Daniel L. Parsons

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel L. Parsons. A scholar is included among the top collaborators of Daniel L. Parsons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel L. Parsons. Daniel L. Parsons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Betageri, Guru V., Sarah Howard Jenkins, & Daniel L. Parsons. (2024). Liposome Drug Delivery Systems. 2 indexed citations

Davis, Virginia A., et al.. (2012). Amorphous-State Characterization of Efavirenz—Polymer Hot-Melt Extrusion Systems for Dissolution Enhancement. Journal of Pharmaceutical Sciences. 101(9). 3456–3464. 119 indexed citations

Parsons, Daniel L., et al.. (2010). In vitropercutaneous absorption of genistein from topical gels through human skin. Drug Development and Industrial Pharmacy. 37(5). 498–505. 28 indexed citations

Babu, R. Jayachandra, William R. Ravis, Sue H. Duran, et al.. (2009). Enhancement of transdermal delivery of phenylbutazone from liposomal gel formulations through deer skin. Journal of Veterinary Pharmacology and Therapeutics. 32(4). 388–392. 4 indexed citations

Parsons, Daniel L., et al.. (2009). Physicochemical Characterization of Efavirenz–Cyclodextrin Inclusion Complexes. AAPS PharmSciTech. 10(1). 81–87. 87 indexed citations

Ravis, William R., et al.. (2009). Gefitinib–cyclodextrin inclusion complexes: physico-chemical characterization and dissolution studies. Drug Development and Industrial Pharmacy. 35(9). 1113–1120. 47 indexed citations

Kolli, Chandra Sekhar, et al.. (2009). Transdermal iontophoretic delivery of selegiline hydrochloride,in vitro. Journal of drug targeting. 18(9). 657–664. 13 indexed citations

Parsons, Daniel L., et al.. (1992). Salicylate binding by human albumin in the presence of a perfluorochemical emulsion.. PubMed. 310. 5–12. 1 indexed citations

Betageri, G. V. & Daniel L. Parsons. (1992). Drug encapsulation and release from multilamellar and unilamellar liposomes. International Journal of Pharmaceutics. 81(2-3). 235–241. 77 indexed citations

10.

Ravis, William R., John F. Hoke, & Daniel L. Parsons. (1991). Perfluorochemical Erythrocyte Substitutes: Disposition and Effects on Drug Distribution and Elimination. Drug Metabolism Reviews. 23(3-4). 375–411. 16 indexed citations

11.

Parsons, Daniel L., et al.. (1991). Human Albumin Binding of Tamoxifen in the Presence of a Perfluorochemical Erythrocyte Substitute. Journal of Pharmacy and Pharmacology. 43(11). 790–793. 9 indexed citations

12.

Gupta, Anand, et al.. (1990). Central and Cardiovascular Effects of the Alcoholic Extract of the Leaves of Carica papaya. International Journal of Crude Drug Research. 28(4). 257–266. 21 indexed citations

13.

Parsons, Daniel L., et al.. (1988). Effects of a Perfluorochemical Blood Substitute on Diazepam Binding by Human Albumin. Journal of Pharmacy and Pharmacology. 40(10). 684–688. 7 indexed citations

14.

Parsons, Daniel L. & Suchita Nadkarni. (1987). Effects of perfluorochemical emulsion components on human albumin binding of warfarin.. PubMed. 288(2). 165–74. 3 indexed citations

15.

Parsons, Daniel L.. (1980). Determination of ligand—macromolecule binding parameters and the method of Hummel and Dreyer. Journal of Chromatography A. 193(3). 520–521. 10 indexed citations

16.

Parsons, Daniel L.. (1980). Analysis of fluorescence quenching data by the method of Levine.. Clinical Chemistry. 26(13). 1869–1871. 4 indexed citations

17.

Parsons, Daniel L. & J.J. Vallner. (1979). Dynamic Dialysis in Drug-Erythrocyte Interactions. Journal of Pharmaceutical Sciences. 68(5). 546–551. 1 indexed citations

18.

Parsons, Daniel L. & J.J. Vallner. (1978). Theoretical models for cooperative binding—I. one-site creator of binding sites. Mathematical Biosciences. 41(3-4). 189–215. 10 indexed citations

19.

Parsons, Daniel L. & J.J. Vallner. (1978). Scatchard Plot Analysis of Ligand-Erythrocyte Interactions. Journal of Pharmaceutical Sciences. 67(9). 1344–1345. 1 indexed citations

20.

Vallner, J.J., Larry A. Sternson, & Daniel L. Parsons. (1976). Interaction of dantrolene sodium with human serum albumin. Journal of Pharmaceutical Sciences. 65(6). 873–877. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact